JP2007300927A5 - - Google Patents

Download PDF

Info

Publication number
JP2007300927A5
JP2007300927A5 JP2007134209A JP2007134209A JP2007300927A5 JP 2007300927 A5 JP2007300927 A5 JP 2007300927A5 JP 2007134209 A JP2007134209 A JP 2007134209A JP 2007134209 A JP2007134209 A JP 2007134209A JP 2007300927 A5 JP2007300927 A5 JP 2007300927A5
Authority
JP
Japan
Prior art keywords
antibody
seq
amino acid
set forth
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007134209A
Other languages
English (en)
Japanese (ja)
Other versions
JP4331227B2 (ja
JP2007300927A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007134209A priority Critical patent/JP4331227B2/ja
Priority claimed from JP2007134209A external-priority patent/JP4331227B2/ja
Publication of JP2007300927A publication Critical patent/JP2007300927A/ja
Publication of JP2007300927A5 publication Critical patent/JP2007300927A5/ja
Application granted granted Critical
Publication of JP4331227B2 publication Critical patent/JP4331227B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007134209A 2004-07-09 2007-05-21 抗グリピカン３抗体 Expired - Fee Related JP4331227B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007134209A JP4331227B2 (ja) 2004-07-09 2007-05-21 抗グリピカン３抗体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004203637 2004-07-09
JP2007134209A JP4331227B2 (ja) 2004-07-09 2007-05-21 抗グリピカン３抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006524550A Division JP4011100B2 (ja) 2004-07-09 2005-07-08 抗グリピカン３抗体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009113159A Division JP2009232848A (ja) 2004-07-09 2009-05-08 抗グリピカン３抗体

Publications (3)

Publication Number Publication Date
JP2007300927A JP2007300927A (ja) 2007-11-22
JP2007300927A5 true JP2007300927A5 (https=) 2008-08-21
JP4331227B2 JP4331227B2 (ja) 2009-09-16

Family

ID=38835421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007134209A Expired - Fee Related JP4331227B2 (ja) 2004-07-09 2007-05-21 抗グリピカン３抗体

Country Status (1)

Country Link
JP (1) JP4331227B2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009000647A1 (es) * 2008-04-04 2010-06-04 Chugai Pharmaceutical Co Ltd Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto.
TWI693073B (zh) * 2012-12-21 2020-05-11 日商中外製藥股份有限公司 對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
JP6827319B2 (ja) 2014-05-08 2021-02-10 中外製薬株式会社 Ｇｐｃ３標的治療剤療法が有効である患者に投与されるｇｐｃ３標的治療剤
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
JP7096667B2 (ja) 2015-07-01 2022-07-06 中外製薬株式会社 Ｇｐｃ３標的治療剤が有効である患者に投与されるｇｐｃ３標的治療剤
CN114080452B (zh) * 2019-06-27 2025-06-03 优特力克斯有限公司 具有4-1bb共刺激结构域的嵌合抗原受体

Similar Documents

Publication Publication Date Title
NZ602892A (en) Antibodies that bind human cd27 and uses thereof
JP2013502204A5 (https=)
JP2016196468A5 (https=)
RU2571204C3 (ru) Специфические связывающие агенты против в7-н1
JP2016185981A5 (https=)
JP2010511388A5 (https=)
HRP20160584T1 (hr) Novo anti-dr5 antitijelo
NZ628584A (en) Ang2-binding molecules
NZ605980A (en) Anti-fap antibodies and methods of use
FI3309176T3 (fi) Immunoglobuliinin yksittäinen vaihteleva domeeni -vasta-aineita ox40l:ää vastaan, konstrukteja ja niiden terapeuttinen käyttö
IL182662A (en) Antibody for Glyphican Antigen 3 and Methods for Preparation
WO2008112004A3 (en) ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF
TWI455946B (zh) 抗磷脂醯肌醇蛋白聚糖３抗體
RU2012110587A (ru) Терапевтические способы и композиции
HRP20130922T1 (hr) U potpunosti humana protutijela protiv humanog 4-1bb (cd137)
JP2016538830A5 (https=)
HRP20211444T1 (hr) Anti-dll3 antitijelo
SG151284A1 (en) Antibodies against ccr5 and uses thereof
IL273841B1 (en) Antibodies targeting cd137 and methods of use thereof
JP2016527273A5 (https=)
WO2007120693A3 (en) Targeted binding agents directed to upar and uses thereof
JP2007300927A5 (https=)
HRP20170254T1 (hr) Humanizirana i kimerna monoklonska protutijela usmjerena na cd47
JP2012510461A5 (https=)
JP2012502649A5 (https=)